1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Hemodialysis and Peritoneal Dialysis Market, by Dialysis Type
7.1.1. Hemodialysis
7.1.1.1. Market Revenue and Forecast
7.1.2. Peritoneal Dialysis
7.1.2.1. Market Revenue and Forecast
8.1. Hemodialysis and Peritoneal Dialysis Market, by Product
8.1.1. Dialysis Machines
8.1.1.1. Market Revenue and Forecast
8.1.2. Dialyzers
8.1.2.1. Market Revenue and Forecast
8.1.3. Dialysis Catheters
8.1.3.1. Market Revenue and Forecast
8.1.4. Bloodline Systems
8.1.4.1. Market Revenue and Forecast
8.1.5. Dialysis Concentrates & Solutions
8.1.5.1. Market Revenue and Forecast
8.1.6. Consumables & Accessories
8.1.6.1. Market Revenue and Forecast
9.1. Hemodialysis and Peritoneal Dialysis Market, by Modality
9.1.1. Conventional Hemodialysis
9.1.1.1. Market Revenue and Forecast
9.1.2. High-Flux Hemodialysis
9.1.2.1. Market Revenue and Forecast
9.1.3. Hemodiafiltration (HDF)
9.1.3.1. Market Revenue and Forecast
9.1.4. Continuous Renal Replacement Therapy (CRRT)
9.1.4.1. Market Revenue and Forecast
9.1.5. Continuous Ambulatory Peritoneal Dialysis
9.1.5.1. Market Revenue and Forecast
10.1. Hemodialysis and Peritoneal Dialysis Market, by End User
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast
10.1.2. Dialysis Centers
10.1.2.1. Market Revenue and Forecast
10.1.3. Home Care Settings
10.1.3.1. Market Revenue and Forecast
10.1.4. Ambulatory Surgical Centers
10.1.4.1. Market Revenue and Forecast
10.1.5. Specialty Kidney Clinics
10.1.5.1. Market Revenue and Forecast
11.1. Hemodialysis and Peritoneal Dialysis Market, by Age Group
11.1.1. Pediatric
11.1.1.1. Market Revenue and Forecast
11.1.2. Adult
11.1.2.1. Market Revenue and Forecast
11.1.3. Geriatric
11.1.3.1. Market Revenue and Forecast
12.1. Hemodialysis and Peritoneal Dialysis Market, by Indication
12.1.1. Chronic Kidney Disease (CKD)
12.1.1.1. Market Revenue and Forecast
12.1.2. End-Stage Renal Disease (ESRD)
12.1.2.1. Market Revenue and Forecast
12.1.3. Acute Kidney Injury (AKI)
12.1.3.1. Market Revenue and Forecast
13.1. Hemodialysis and Peritoneal Dialysis Market, by Treatment Setting
13.1.1. In-center Treatment
13.1.1.1. Market Revenue and Forecast
13.1.2. Home-based Treatment
13.1.2.1. Market Revenue and Forecast
14.1. Hemodialysis and Peritoneal Dialysis Market, by Payer
14.1.1. Public Healthcare
14.1.1.1. Market Revenue and Forecast
14.1.2. Private Insurance
14.1.2.1. Market Revenue and Forecast
14.1.3. Out-of-Pocket
14.1.3.1. Market Revenue and Forecast
15.1. North America
15.1.1. Market Revenue and Forecast, by Dialysis Type
15.1.2. Market Revenue and Forecast, by Product
15.1.3. Market Revenue and Forecast, by Modality
15.1.4. Market Revenue and Forecast, by End User
15.1.5. Market Revenue and Forecast, by Age Group
15.1.6. Market Revenue and Forecast, by Indication
15.1.7. Market Revenue and Forecast, by Treatment Setting
15.1.8. Market Revenue and Forecast, by Payer
15.1.9. U.S.
15.1.9.1. Market Revenue and Forecast, by Dialysis Type
15.1.9.2. Market Revenue and Forecast, by Product
15.1.9.3. Market Revenue and Forecast, by Modality
15.1.9.4. Market Revenue and Forecast, by End User
15.1.9.5. Market Revenue and Forecast, by Age Group
15.1.9.6. Market Revenue and Forecast, by Indication
15.1.9.7. Market Revenue and Forecast, by Treatment Setting
15.1.9.8. Market Revenue and Forecast, by Payer
15.1.10. Rest of North America
15.1.10.1. Market Revenue and Forecast, by Dialysis Type
15.1.10.2. Market Revenue and Forecast, by Product
15.1.10.3. Market Revenue and Forecast, by Modality
15.1.10.4. Market Revenue and Forecast, by End User
15.1.10.5. Market Revenue and Forecast, by Age Group
15.1.10.6. Market Revenue and Forecast, by Indication
15.1.10.7. Market Revenue and Forecast, by Treatment Setting
15.1.10.8. Market Revenue and Forecast, by Payer
15.2. Europe
15.2.1. Market Revenue and Forecast, by Dialysis Type
15.2.2. Market Revenue and Forecast, by Product
15.2.3. Market Revenue and Forecast, by Modality
15.2.4. Market Revenue and Forecast, by End User
15.2.5. Market Revenue and Forecast, by Age Group
15.2.6. Market Revenue and Forecast, by Indication
15.2.7. Market Revenue and Forecast, by Treatment Setting
15.2.8. Market Revenue and Forecast, by Payer
15.2.9. UK
15.2.9.1. Market Revenue and Forecast, by Dialysis Type
15.2.9.2. Market Revenue and Forecast, by Product
15.2.9.3. Market Revenue and Forecast, by Modality
15.2.9.4. Market Revenue and Forecast, by End User
15.2.9.5. Market Revenue and Forecast, by Age Group
15.2.9.6. Market Revenue and Forecast, by Indication
15.2.9.7. Market Revenue and Forecast, by Treatment Setting
15.2.9.8. Market Revenue and Forecast, by Payer
15.2.10. Germany
15.2.10.1. Market Revenue and Forecast, by Dialysis Type
15.2.10.2. Market Revenue and Forecast, by Product
15.2.10.3. Market Revenue and Forecast, by Modality
15.2.10.4. Market Revenue and Forecast, by End User
15.2.10.5. Market Revenue and Forecast, by Age Group
15.2.10.6. Market Revenue and Forecast, by Indication
15.2.10.7. Market Revenue and Forecast, by Treatment Setting
15.2.10.8. Market Revenue and Forecast, by Payer
15.2.11. France
15.2.11.1. Market Revenue and Forecast, by Dialysis Type
15.2.11.2. Market Revenue and Forecast, by Product
15.2.11.3. Market Revenue and Forecast, by Modality
15.2.11.4. Market Revenue and Forecast, by End User
15.2.11.5. Market Revenue and Forecast, by Age Group
15.2.11.6. Market Revenue and Forecast, by Indication
15.2.11.7. Market Revenue and Forecast, by Payer
15.2.11.8. Market Revenue and Forecast, by Treatment Setting
15.2.12. Rest of Europe
15.2.12.1. Market Revenue and Forecast, by Dialysis Type
15.2.12.2. Market Revenue and Forecast, by Product
15.2.12.3. Market Revenue and Forecast, by Modality
15.2.12.4. Market Revenue and Forecast, by End User
15.2.12.5. Market Revenue and Forecast, by Age Group
15.2.12.6. Market Revenue and Forecast, by Indication
15.2.12.7. Market Revenue and Forecast, by Treatment Setting
15.2.12.8. Market Revenue and Forecast, by Payer
15.3. APAC
15.3.1. Market Revenue and Forecast, by Dialysis Type
15.3.2. Market Revenue and Forecast, by Product
15.3.3. Market Revenue and Forecast, by Modality
15.3.4. Market Revenue and Forecast, by End User
15.3.5. Market Revenue and Forecast, by Age Group
15.3.6. Market Revenue and Forecast, by Indication
15.3.7. Market Revenue and Forecast, by Treatment Setting
15.3.8. Market Revenue and Forecast, by Payer
15.3.9. India
15.3.9.1. Market Revenue and Forecast, by Dialysis Type
15.3.9.2. Market Revenue and Forecast, by Product
15.3.9.3. Market Revenue and Forecast, by Modality
15.3.9.4. Market Revenue and Forecast, by End User
15.3.9.5. Market Revenue and Forecast, by Age Group
15.3.9.6. Market Revenue and Forecast, by Indication
15.3.9.7. Market Revenue and Forecast, by Treatment Setting
15.3.9.8. Market Revenue and Forecast, by Payer
15.3.10. China
15.3.10.1. Market Revenue and Forecast, by Dialysis Type
15.3.10.2. Market Revenue and Forecast, by Product
15.3.10.3. Market Revenue and Forecast, by Modality
15.3.10.4. Market Revenue and Forecast, by End User
15.3.10.5. Market Revenue and Forecast, by Age Group
15.3.10.6. Market Revenue and Forecast, by Indication
15.3.10.7. Market Revenue and Forecast, by Treatment Setting
15.3.10.8. Market Revenue and Forecast, by Payer
15.3.11. Japan
15.3.11.1. Market Revenue and Forecast, by Dialysis Type
15.3.11.2. Market Revenue and Forecast, by Product
15.3.11.3. Market Revenue and Forecast, by Modality
15.3.11.4. Market Revenue and Forecast, by End User
15.3.11.5. Market Revenue and Forecast, by Age Group
15.3.11.6. Market Revenue and Forecast, by Indication
15.3.11.7. Market Revenue and Forecast, by Treatment Setting
15.3.11.8. Market Revenue and Forecast, by Payer
15.3.12. Rest of APAC
15.3.12.1. Market Revenue and Forecast, by Dialysis Type
15.3.12.2. Market Revenue and Forecast, by Product
15.3.12.3. Market Revenue and Forecast, by Modality
15.3.12.4. Market Revenue and Forecast, by End User
15.3.12.5. Market Revenue and Forecast, by Age Group
15.3.12.6. Market Revenue and Forecast, by Indication
15.3.12.7. Market Revenue and Forecast, by Treatment Setting
15.3.12.8. Market Revenue and Forecast, by Payer
15.4. MEA
15.4.1. Market Revenue and Forecast, by Dialysis Type
15.4.2. Market Revenue and Forecast, by Product
15.4.3. Market Revenue and Forecast, by Modality
15.4.4. Market Revenue and Forecast, by End User
15.4.5. Market Revenue and Forecast, by Age Group
15.4.6. Market Revenue and Forecast, by Indication
15.4.7. Market Revenue and Forecast, by Treatment Setting
15.4.8. Market Revenue and Forecast, by Payer
15.4.9. GCC
15.4.9.1. Market Revenue and Forecast, by Dialysis Type
15.4.9.2. Market Revenue and Forecast, by Product
15.4.9.3. Market Revenue and Forecast, by Modality
15.4.9.4. Market Revenue and Forecast, by End User
15.4.9.5. Market Revenue and Forecast, by Age Group
15.4.9.6. Market Revenue and Forecast, by Indication
15.4.9.7. Market Revenue and Forecast, by Treatment Setting
15.4.9.8. Market Revenue and Forecast, by Payer
15.4.10. North Africa
15.4.10.1. Market Revenue and Forecast, by Dialysis Type
15.4.10.2. Market Revenue and Forecast, by Product
15.4.10.3. Market Revenue and Forecast, by Modality
15.4.10.4. Market Revenue and Forecast, by End User
15.4.10.5. Market Revenue and Forecast, by Age Group
15.4.10.6. Market Revenue and Forecast, by Indication
15.4.10.7. Market Revenue and Forecast, by Treatment Setting
15.4.10.8. Market Revenue and Forecast, by Payer
15.4.11. South Africa
15.4.11.1. Market Revenue and Forecast, by Dialysis Type
15.4.11.2. Market Revenue and Forecast, by Product
15.4.11.3. Market Revenue and Forecast, by Modality
15.4.11.4. Market Revenue and Forecast, by End User
15.4.11.5. Market Revenue and Forecast, by Age Group
15.4.11.6. Market Revenue and Forecast, by Indication
15.4.11.7. Market Revenue and Forecast, by Treatment Setting
15.4.11.8. Market Revenue and Forecast, by Payer
15.4.12. Rest of MEA
15.4.12.1. Market Revenue and Forecast, by Dialysis Type
15.4.12.2. Market Revenue and Forecast, by Product
15.4.12.3. Market Revenue and Forecast, by Modality
15.4.12.4. Market Revenue and Forecast, by End User
15.4.12.5. Market Revenue and Forecast, by Age Group
15.4.12.6. Market Revenue and Forecast, by Indication
15.4.12.7. Market Revenue and Forecast, by Treatment Setting
15.4.12.8. Market Revenue and Forecast, by Payer
15.5. Latin America
15.5.1. Market Revenue and Forecast, by Dialysis Type
15.5.2. Market Revenue and Forecast, by Product
15.5.3. Market Revenue and Forecast, by Modality
15.5.4. Market Revenue and Forecast, by End User
15.5.5. Market Revenue and Forecast, by Age Group
15.5.6. Market Revenue and Forecast, by Indication
15.5.7. Market Revenue and Forecast, by Treatment Setting
15.5.8. Market Revenue and Forecast, by Payer
15.5.9. Brazil
15.5.9.1. Market Revenue and Forecast, by Dialysis Type
15.5.9.2. Market Revenue and Forecast, by Product
15.5.9.3. Market Revenue and Forecast, by Modality
15.5.9.4. Market Revenue and Forecast, by End User
15.5.9.5. Market Revenue and Forecast, by Age Group
15.5.9.6. Market Revenue and Forecast, by Indication
15.5.9.7. Market Revenue and Forecast, by Treatment Setting
15.5.9.8. Market Revenue and Forecast, by Payer
15.5.10. Rest of LATAM
15.5.10.1. Market Revenue and Forecast, by Dialysis Type
15.5.10.2. Market Revenue and Forecast, by Product
15.5.10.3. Market Revenue and Forecast, by Modality
15.5.10.4. Market Revenue and Forecast, by End User
15.5.10.5. Market Revenue and Forecast, by Age Group
15.5.10.6. Market Revenue and Forecast, by Indication
15.5.10.7. Market Revenue and Forecast, by Treatment Setting
15.5.10.8. Market Revenue and Forecast, by Payer
16.1. Asahi Kasei Corporation
16.1.1. Company Overview
16.1.2. Product Offerings
16.1.3. Financial Performance
16.1.4. Recent Initiatives
16.2. Baxter International
16.2.1. Company Overview
16.2.2. Product Offerings
16.2.3. Financial Performance
16.2.4. Recent Initiatives
16.3. Fresenius Medical Care
16.3.1. Company Overview
16.3.2. Product Offerings
16.3.3. Financial Performance
16.3.4. Recent Initiatives
16.4. Nipro Corporation
16.4.1. Company Overview
16.4.2. Product Offerings
16.4.3. Financial Performance
16.4.4. Recent Initiatives
16.5. Nikkiso Co. Ltd.
16.5.1. Company Overview
16.5.2. Product Offerings
16.5.3. Financial Performance
16.5.4. Recent Initiatives
16.6. Becton, Dickinson, and Company
16.6.1. Company Overview
16.6.2. Product Offerings
16.6.3. Financial Performance
16.6.4. Recent Initiatives
16.7. B. Braun
16.7.1. Company Overview
16.7.2. Product Offerings
16.7.3. Financial Performance
16.7.4. Recent Initiatives
16.8. Toray Industries Ltd.
16.8.1. Company Overview
16.8.2. Product Offerings
16.8.3. Financial Performance
16.8.4. Recent Initiatives
16.9. Diaverum
16.9.1. Company Overview
16.9.2. Product Offerings
16.9.3. Financial Performance
16.9.4. Recent Initiatives
16.10. Abbott
16.10.1. Company Overview
16.10.2. Product Offerings
16.10.3. Financial Performance
16.10.4. Recent Initiatives
16.7. Primary Research
16.7. Secondary Research
16.7. Assumptions
18.1. About Us
18.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
